InsidersTradesSigma
Track the AXIM BIOTECHNOLOGIES, INC. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €1m. The latest transaction was disclosed on 15 October 2024 (Acquisition). Among the most active insiders: Valencia Catalina. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
AXIM BIOTECHNOLOGIES, INC. is a company focused on developing biopharmaceutical products, particularly for pain management and cannabis-related diseases. It is listed on NASDAQ under the ticker symbol AXIM.